Inventor · disambiguated record
Stephan Siegel
Also filed as: SIEGEL STEPHAN
9 granted patents·14 pending applications·30 citations·filing 2002–2024
83Inventor score
Top patents by PatentIndex Score
23 records- 0184US9434731B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useBAYER IP GMBH·Filed 2013·Granted Sep 6, 2016·8 cites·3 claims
- 0284US8273752B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2008·Granted Sep 25, 2012·11 cites·5 claims
- 0379US8198267B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jun 12, 2012·7 cites·8 claims
- 0474US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 0571US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 0670US8436003B2Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazinesSIEGEL STEPHAN·Filed 2009·Granted May 7, 2013·1 cites·7 claims
- 0768US8664246B2Substituted pyridines, and use thereof as GSK3 inhibitorsSIEGEL STEPHAN·Filed 2009·Granted Mar 4, 2014·1 cites·8 claims
- 0862US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 0960US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1056US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 1155US8476267B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useSIEGEL STEPHAN·Filed 2008·Granted Jul 2, 2013·0 cites·7 claims
- 1254US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 1349US2009258877A1Triazolotriazines and triazolopyrazines and their useBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1448US12403135B24H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2020·Granted Sep 2, 2025·0 cites·16 claims
- 1548US2013296343A1Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazinesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 1647US9051323B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2012·Granted Jun 9, 2015·0 cites·6 claims
- 1747US2010105663A12-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitorsBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1846US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 1946US2011243846A1Benzothiazole amides for detection of amyloid betaHASSFELD JORMA·Filed 2009·Application pending·0 cites
- 2044US2007117860A1Bicyclic indolinesulphonamide derivativesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 2143US2007185183A1Indolinesulphanilic acid amides as ppar-delta modulatorsBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 2243US2007197626A1Indoline derivativesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 2336US2005043341A13-'Hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7 8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephan Siegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →